Latest Monoclonal antibodies Stories
THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Company has commenced termination of its participation in the co-development and commercialization
Includes study in patients who were inadequate responders to or intolerant of TNF-alpha inhibitors TARRYTOWN, N.Y. and PARIS, May 21, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
New report “Global Multiple Myeloma Drug Market & Pipeline Insight 2015” developed by Kuick Research is now available at MarketPublishers.com. London,
DUBLIN, May 19, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/47gwnj/antibody) has announced the addition of the "Antibody Production
MAINZ, Germany, May 19, 2015 /PRNewswire/ -- Collaboration with Genmab will focus on novel bispecific antibody products in immuno-oncology BioNTech AG, a
ATLANTA, May 16, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company focusing on immunology and neurology treatment and research, is sponsoring several data presentations on Cimzia(®) (certolizumab
- Orphan Drug Designation program provides orphan status to medications intended for the safe and effective treatment, diagnosis or prevention of rare diseases NORTH CHICAGO, Ill., May 15,
LONDON, May 13, 2015 /PRNewswire/ -- INTRODUCTIONThe concept of bispecific antibodies is increasingly gaining traction in the pharma industry owing to several therapeutic
MONROVIA, Calif., May 11, 2015 /PRNewswire/ -- Xencor, Inc.
OXFORD, England, May 11, 2015 /PRNewswire/ -- Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer, viral infections
- A handkerchief.
- In general, any miraculous portrait of Christ.
More Images (1 images) »